Blue Owl Capital Holdings »

Rezolve Ai shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Rezolve Ai shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Rezolve Ai

Tip: Access up to 7 years of quarterly data

All positions including Rezolve Ai held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolve Ai by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $85k 603k 0.14

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Rezolve Ai

Blue Owl Capital Holdings
Polar Securities
MMCAP International Inc. SPC
CSS
Warberg Asset Management
Q Global Advisors
Corbin Capital Partners
K2 Principal Fund
Susquehanna International
Whitebox Advisors
Cowen And Company
Wolverine Asset Management
Bank of America Corporation

View all funds holding Rezolve Ai